Protagonist Therapeutics Inc (PTGX)
Equity Ratio
95.03%
Quarterly · Period ending:
PTGX Equity Ratio
Latest reported95.03%period ending
Latest reported95.03%period ending
PTGX Quarterly Equity Ratio (64.64% → 95.03%)
Latest values, visible window
High-resolution chart · PNG
PTGX equity ratio history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Equity Ratio |
|---|---|
| 95.0312% | |
| 93.9801% | |
| 91.762% | |
| 91.9835% | |
| 93.0379% | |
| 92.8476% | |
| 90.6771% | |
| 88.0863% | |
| 88.0733% | |
| 89.0617% | |
| 94.0567% | |
| 91.5559% | |
| 91.7626% | |
| 90.1229% | |
| 86.964% | |
| 86.3354% | |
| 86.302% | |
| 86.6441% | |
| 86.2886% | |
| 88.3393% | |
| 88.4262% | |
| 87.0038% | |
| 86.1737% | |
| 78.037% | |
| 74.4444% | |
| 46.4533% | |
| 51.6173% | |
| 61.6697% | |
| 56.9299% | |
| 76.2393% | |
| -100.7184% | |
| 83.2738% | |
| 78.315% | |
| 76.8037% | |
| -62.0213% | |
| -89.2071% | |
| 86.5932% | |
| 90.5906% | |
| -68.7233% | |
| 94.7989% | |
| 83.2354% | |
| 82.8133% | |
| 64.6413% |